Tylenol Sinus Severe Tablet, Coated
NDC Package 70264-026-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Tylenol Sinus Severe (acetaminophen) tablets is a medication used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever. This formulation utilizes a tablet, coated delivery system. Marketed by R J General Corporation, this product is identified by NDC 70264-026 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
70264-026-02
Package Description
50 POUCH in 1 BOX / 2 TABLET, COATED in 1 POUCH
Product Code
70264-026
11-Digit Billing Format
70264002602
RxNorm Crosswalk
  • RxCUI: 1243679 - acetaminophen 325 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet
  • RxCUI: 1243679 - acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1243679 - APAP 325 MG / GG 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet
  • RxCUI: 1243679 - APAP 325 MG / Guaifenesin 200 MG / Phenylephrine Hydrochloride 5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Tylenol Sinus Severe
Non-Proprietary Name
Acetaminophen
Substance Name
Acetaminophen; Guaifenesin; Phenylephrine Hydrochloride
Dosage Form
Tablet, Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.

Regulatory & Marketing

Labeler Name
R J General Corporation
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
05-01-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70264-026-02 identifies a specific commercial package of 50 pouch in 1 box / 2 tablet, coated in 1 pouch of Tylenol Sinus Severe, a human over the counter drug labeled by R J General Corporation. This tablet, coated is formulated for oral use and contains acetaminophen; guaifenesin; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by R J General Corporation on May 01, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This drug is used to treat mild to moderate pain (from headaches, menstrual periods, toothaches, backaches, osteoarthritis, or cold/flu aches and pains) and to reduce fever.

How is this R J General Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70264002602. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70264-026-02
11-Digit CMS (5-4-2)
70264-0026-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.